Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Metadata
Title
Severity of nephrotic IgA nephropathy according to the Oxford classification
Publication date
01-08-2012
Published in
International Urology and Nephrology / Issue 4/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0109-5

Other articles of this Issue 4/2012

International Urology and Nephrology 4/2012 Go to the issue

Urology – Case Report

Primary adenocarcinoma of the epididymis: the therapeutic role of retroperitoneal lymphadenectomy

Nephrology - Original Paper

Non-compliance to the continuous ambulatory peritoneal dialysis procedure increases the risk of peritonitis

Nephrology – Case Report

Renal cocktail: too hard for a diabetic

Urology - Original Paper

Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?

Urology – Original Paper

Goserelin versus leuprolide in the chemical castration of patients with prostate cancer

Urology – Case Report

Bladder carcinoma in a 31-year-old female spina bifida patient with an auto-augmented bladder

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits